Cypress Capital Group Purchases 3,307 Shares of Colgate-Palmolive (NYSE:CL)

Cypress Capital Group lifted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 12.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,647 shares of the company's stock after acquiring an additional 3,307 shares during the quarter. Cypress Capital Group's holdings in Colgate-Palmolive were worth $2,695,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in CL. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive in the fourth quarter valued at about $26,000. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth about $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth about $32,000. Bernard Wealth Management Corp. acquired a new position in Colgate-Palmolive during the fourth quarter valued at approximately $36,000. Finally, Roxbury Financial LLC acquired a new position in Colgate-Palmolive during the fourth quarter valued at approximately $43,000. Institutional investors own 80.41% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CL. JPMorgan Chase & Co. dropped their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. Piper Sandler lowered their target price on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research note on Monday, January 6th. StockNews.com upgraded Colgate-Palmolive from a "hold" rating to a "buy" rating in a research note on Monday. Royal Bank of Canada restated a "sector perform" rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, UBS Group reduced their target price on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a report on Monday, February 3rd. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $101.61.

Colgate-Palmolive Stock Up 0.9 %

Shares of Colgate-Palmolive stock traded up $0.81 on Wednesday, hitting $91.87. The company had a trading volume of 3,446,465 shares, compared to its average volume of 4,103,554. The stock has a market capitalization of $74.56 billion, a price-to-earnings ratio of 26.10, a P/E/G ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The stock has a 50 day moving average of $88.72 and a 200-day moving average of $95.27. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the firm earned $0.87 earnings per share. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.18%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio is presently 56.82%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.